ANI Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

• ANI Pharmaceuticals Inc ANIP.OQ reported quarterly adjusted earnings of $1.80​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $1.21. The mean expectation of eight analysts for the quarter was for earnings of $1.42 per share. Wall Street expected results to range from $1.27 to $1.59 per share.

• Revenue rose 53.8% to $211.37 million from a year ago; analysts expected $190.29 million.

• ANI Pharmaceuticals Inc's reported EPS for the quarter was 69 cents​.

• The company reported quarterly net income of $8.14 million.

• ANI Pharmaceuticals Inc shares had risen by 5.8% this quarter and gained 24.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2.2% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for ANI Pharmaceuticals Inc is $84.00, about 17.8% above its last closing price of $69.01

This summary was machine generated from LSEG data August 8 at 01:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)